SlideShare a Scribd company logo
RHEUMATIC FEVER
DR SHADAB
INTRODUCTION
Rheumatic fever- a multifactorial disease that follows GAS pharyngitis in a
susceptible individual who lives under deprived social conditions,
characterized by acute inflammation of the heart, joints, skin, subcutaneous
tissue & CNS, that gives rise to typical clinical feature including
• Arthritis
• Carditis
• Chorea
• Subcutaneous nodules &
• Erythema marginatum
• Latent period of 2-3 weeks following GAS pharangitis
• Destructive effects on heart valves leads to RHD with serious hemodynamic
disturbances causing HF, stroke & infective endocarditis
EPIDEMIOLOGY
• Ages 4-15 years are most
susceptible
• In developing countries (such as
Saudi Arabia & India), juvenile
MS may occur at age 3-5 years
• Rare in <3 years
PATHOGENESIS
• GAS pharyngitis triggers an
autoimmune response to epitopes
in the organism that cross react
with similar epitopes in the heart,
brain, joints and skin , and
repeated episodes of rheumatic
fever lead to RHD (theory of
molecular mimicry)
GAS PHARYNGITIS
ARTHRITIS
• Joint involvement is more common (almost 100%), more
severe in young adults than in teenagers (82%), &
children(66%)
• Migratory arthritis- sequential involvement of joints with
inflammation resolving in one joint & then begins in another
joint (sometimes may be additive)
• Usually Subside within days to 1 week, may last for another 1-
2 weeks, if persist after 4 weeks, it becomes necessary to
consider other conditions such as juvenile idiopathic arthritis
or SLE
• Large joints- knee, ankle, elbow & wrists are most frequently
involved
• Hip , shoulder, and small joints of hands & feet are less
frequently involved
• Respond promptly to NSAIDS
JACCOUD ARTHRITIS
• Chronic post-rheumatic fever arthropathy
• Ulnar deviation of fingers (esp. 4th & 5th
finfers), flexion of metacarpophalangeal
joints, & hyperextension of proximal
interphalangeal joints (i.e., swan neck
deformity)
• Usually painless & no signs of inflammation
• Results from recurrent inflammation of
fibrous articular capsule & there are no true
erosion on xray
• Rheumatoid factors are usually negative
CARDITIS
• Incidence of carditis varies with age with
first attack of rheumatic fever:
• 90-92% of children age<3 years
• 50% of children age 3-6 years
• 32% of teenagers age 14-17 years
• 15% of adults
• Symptoms & signs depend on involvement
of endocardium (heart valves), myocardium
& pericardium
• Most serious manifestation of rheumatic
fever
ENDOCARDITIS/VALVULITIS
• Almost always associated with a murmur of valvulitis
• An universal finding in rheumatic carditis, whereas the
presence of pericarditis or myocarditis is variable
• Inflammation, edema & fibrin deposits on valve leaflets along
the line of closure(verrucous vegetations)
• Map-like areas of thickened, roughened, and wrinkled part of
the endocardium in the left atrium caused by regurgitant jets
of MR (MacCallum plaque)
• The most common valvular lesion is MR causing an apical
PSM, pathogenesis include valvulitis, mitral annular
dilatation, leaflet prolapse or chordal rupture, AR is less
common.
• Stenotic lesions are uncommon in the early stages , but a
transient apical mid-diastolic murmur (Carey-Coombs) may
occur in association with MR
• With H/O previous RHD, a change in character of murmurs or
appearance of a new murmur will indicate the presence of
acure rheumatic carditis.
MYOCARDITIS
• Almost always associated with valvulitis
• Should be accompanied by an apical systolic or basal
diastolic murmur.
• May develop cardiomegaly & CHF
• ECG changes include varying degree of heart block, with
1st degree heart block are usually asymptomatic
• Patients with 2nd & 3rd degree heart block are
symptomatic and require a pacemaker if they develop
CHF
• Aschoff body consists of a focus of fibrinoid necrosis
(site of Ag-Ab reaction) surrounded by activated
histiocytes (Anitschkow’s cells/caterpillar cells) &
lymphocytes
PERICARDITIS
• Detected clinically in 10% of
patients
• Associated with anterior chest pain
& pericardial friction rub
• Pericardial effusion may be large,
but cardiac tamponade is rare
• Constrictive pericarditis does not
occur
• “Bread & butter” appearance due
to fibrinous inflammation
MINIMUM ECHO CRITERIA FOR DIAGNOSIS OF VALVULAR
REGURGITATION CAUSED BY RHEUMATIC CARDITIS
• All four Doppler criteria must be
met
• A regurgitant jet length should be
measured from the vena
contracta to the last pixel of
regurgitant color on
nonmagnified images.
PATHOLOGIC MR PATHOLOGIC AR
1. Seen in at least two
views
1. Seen in at least two
views
2. In at least one view, jet
length is ≥2 cm
2. In at least one view, jet
length is ≥1 cm
3. Peak velocity ≥3 m/sec 3. Peak velocity ≥3 m/sec
4. Pansystolic jet in at
least one envelope
4. Pansystolic jet in at
least one envelope.
SYDENHAM CHOREA
• May be the only presenting manifestation of rheumatic fever
• Female predominance
• Latent period 6-8 week (longer than arthritis & carditis, 2-3 weeks)
• Usually last for 8-15 weeks (may last for 1 week to 2 years)
• Characterized by the presence of involuntary, purposeless, jerky movements
of hands, arms, shoulders, feet, legs, face & trunk associated with hypotonia
& weakness, sometimes may be unilateral (hemichorea)
• The purposeless movements interfere with voluntary activity & disappear
during sleep
• Jack-in-the-box tongue
• Milking sign
• Chorea does not occur simultaneously with arthritis but may coexist with
carditis
SYDENHAM’S CHOREA VS PANDAS
Sydenham’s chorea PANDAS
Age of onset 5-15 years 3 years – puberty
Gender Female predominance Male > Female
Pathogen Several M-strains of Streptococcal bacteria No unique strain identified
Incidence of psychiatric
disorders in 1st degree relatives
No studies 39% motor or vocal tics, 26% OCD
Neurological abnormalities Hypotonia, Darting tongue, Milkmaid sign,
Pronator sign, choreic hand, dysarthria
Motor hyperactivity, adventitious movements
such as choreiform movements
Psychiatric manifestation Emotional liability, anxiety, tics, OCD in
70% of patients
Emotional liability, separation anxiety, night
time fears, oppositional behaviors
ASO titer Elevated in 80% of cases Temporal relation with ASO
Duration of symptoms Usually resolve in 1-6 months, may persist
up to 2 years
Remitting-relapsing course
Anti-basal ganglia antibodies 40, 45, 60 kDa autoantigens molecule 60kDa ABGA very frequently present
MRI Volumetric increase in caudate, putamen &
globus pallidus
Volumetric increase in caudate, putamen, &
globus pallidus
Treatment Benzathine penicillin prophylaxis 1.2 MU
I/M 3 weekly
IVIG & plasma exchange, tonsilectomy
SUBCUTANEOUS NODULES
• Resemble the nodules of rheumatoid
arthritis
• May be detected over occiput,
elbows(over olecranon), knees, ankles,
and Achilles tandons.
• Usually firm, painless, & freely movable
over the subcutaneous tissue
• Size 0.5-2 cm & tend to occur in crops
• Usually smaller, more discrete, &
persistent than rheumatoid nodules
• Persist for few weeks but seldom >1
month
• Multiple crops may be related to the
severity of rheumatic carditis
ERYTHEMA MARGINATUM
• Occur on upper arms or trunk, but
not the face
• The rash is evanescent, pink, and
nonpruritic
• Extend centrifugally while the skin
at the center returns to normal
• Has an irregular serpiginous border
• Rash become more prominent after
a hot shower
DIFFERENTIAL DIAGNOSIS
ARTHRITIS CARDITIS CHOREA
Rheumatoid arthritis Viral myocarditis Huntington chorea
Reactive arthritis (eg., Shigella,
Salmonella, Yersinia)
Viral pericarditis Wilson disease
Serum sickness Infective endocarditis SLE
Sickle cell disease Kawasaki disease Cerebral palsy
Malignancy Congenital heart disease Tics
SLE Mitral valve prolapse Hyperactivity
Lyme disease Innocent murmur
Gonococcal infection
MINOR MANIFESTATIONS
Fever
• Usually raised during attacks
• Ranges from 38.4˚C to 40˚C
• Usually decreases within 1 week & rarely last >4 weeks
Abdominal pain
• May mimic acute appendicitis
Epistaxis
Rapid sleeping pulse rate, tachycardia out of proportion to fever
Malaise
Anemia
Rheumatic pneumonia
EVOLUTION OF JONES CRITERIA
2015 AHA-REVISED JONES CRITERIA FOR DIAGNOSIS OF RHEUMATIC FEVER
MAJOR CRITERIA
LOW-RISK
POPULATIONS
MODERATE & HIGH-
RISK POPULATIONS
1. Carditis
(clinical/subclinical)
Carditis
(clinical/subclinical)
2. Arthritis (polyarthritis
only)
Arthritis (including
polyarthritis, monoarthritis/
polyarthralgia)
3. Chorea Chorea
4. Erythema marginatum Erythema marginatum
5. Subcutaneous nodules Subcutaneous nodules
MINOR CRITERIA
LOW RISK
POPULATIONS
MODERATE & HIGH
RISK POPULATIONS
1. Polyarthralgia Monoarthralgia
2. Fever (≥38.5˚C) Fever (≥38˚C)
3. ESR ≥60 mm in the 1st
hour &/or CRP ≥3.0 mg/dl
ESR ≥30 mm in the 1st hour
&/or CRP ≥3.0 mg/dl
4. Prolonged PR interval,
after accounting for age
variability (unless carditis is
a major criterion)
Prolonged PR interval, after
accounting for age
variability (unless carditis is
a major criterion)
• Joint manifestations are considered in either the major or the minor category, but not in both categories in the same
patient
• Low-risk communities are defined as having an ARF incidence of ≤2 per 100,000 school-aged children (usually 5 to
14 years old) per year, or an all-age prevalence of RHD of ≤1 per 1000 population per year
DIAGNOSIS
• The initial diagnosis of ARF is made if, in the presence of preceding
GAS infection, two major criteria or one major and two minor criteria
are present.
• The diagnosis of recurrent ARF requires two major, one major and
two minor, or three minor criteria in the presence of preceding GAS
infection.
• Evidence of preceding GAS infection, (essential for diagnosis), may
be obtained from
• Throat swab culture (only positive in approx. 11% of patients), or
• By demonstrating a rising titer of antistreptococcal antibodies, either ASO or
anti-Dnase B, or
• By a positive rapid group A streptococcal carbohydrate antigen test in a child
whose clinical presentation suggests a high pretest probability of streptococcal
pharyngitis.
POSSIBLE RHEUMATIC FEVER
• The 2015 Jones criteria also recognize the clinical entity of “possible
rheumatic fever”
• Applied in part of the world where rheumatic fever remains common
and where it is not possible to fulfill the Jones criteria because of a
lack of lab facilities to conduct the recommended investigations of a
patient with suspected rheumatic fever.
• When a diagnosis of possible rheumatic fever is made, it is reasonable
to consider offering 12 months of secondary prophylaxis, followed by
reevaluation based on history, physical examination, and repeat
echocardiogram.
INVESTIGATIONS IN SUSPECTED RHEUMATIC FEVER
Recommended for All Cases Test for Alternative Diagnoses, Depending on
Clinical Features
WBC count Repeated blood culture with temperature spikes if
infective endocarditis is suspected
ESR or CRP Joint aspirate for possible septic arthritis (microscopy
& culture)
Throat swab before giving antibiotics for GAS culture Copper, ceruloplasmin, ANA, and drug screen for
choreiform movements
Blood culture, if febrile Serology and autoimmune markers for arboviral,
autoimmune, or reactive arthritis
Antistreptococcal serology: both ASO & antiDNase B
titers (repeat after 10-14 days if first test is not
confirmatory)
Peripheral blood smear for sickle cell disease
ECG
Chest X-ray
Echocardiogram
TREATMENT
• Bed rest- to lessen joint pain
• Ambulation can usually be started once the fever has subsided and acute phase
reactants are returning to normal
• Sternous exertion should be avoided, esp. for those with carditis
• Antibiotics
• Benzathine benzylpenicillin (Penicillin G)- 1.2 MU I/M single dose (50% if weight
<30 kg)
• Phenoxymethylpenicillin (Penicillin VK)- 250-500 mg oral three times daily for 10
days
• Erythromycin ethylsuccinate- oral for 10 days
• Anti-inflammatory agents
• Aspirin 100mg/kg/day in four to five divided doses for approx. 1 month or until
inflammation has subsided (for milder attack with little or no carditis)
• Prednisone 1-2 mg/kg/day for 2-3 months then graduallt weaned (for more severe
cases)
SECONDARY PREVENTION
ANTIBIOTICS DOSE
Benzathine benzylpenicillin 1.2 MU I/M every 3-4 weeks (for adults & children ≥ 30 kg
weight)
0.6 MU I/M every 3-4 weeks (for children < 30 kg weight)
Penicillin V 250 mg oral twice daily
Sulfonamides (sulfadiazine, sulfadoxine, &
sulfisoxazole)
1 g/day (for adults & children ≥ 30 kg weight)
0.5 g/day (for children < 30 kg weight)
Erythromycin 250 mg twice daily
DURATION OF SECONDARY PROPHYLAXIS
CATEGORY OF PATIENTS DURATION
Patients without proven carditis For 5 years after last attack or until 18 years of age
(whichever is longer)
Patient with carditis (mild MR or healed carditis) For 10 years after last attack or at least until 25 years of age
(whichever is longer)
More severe valvular disease Lifelong
After valve surgery Lifelong
THANK YOU

More Related Content

What's hot

Approach to the child with rash
Approach to the child with rashApproach to the child with rash
Approach to the child with rash
Ajit Gadekar
 

What's hot (20)

Acute rheumatic fever &amp; rheumatic heart disease
Acute rheumatic fever &amp; rheumatic heart diseaseAcute rheumatic fever &amp; rheumatic heart disease
Acute rheumatic fever &amp; rheumatic heart disease
 
Vasculitis
VasculitisVasculitis
Vasculitis
 
Acute rheumatic fever
Acute rheumatic feverAcute rheumatic fever
Acute rheumatic fever
 
CONGENITAL HEART DISEASES: A SIMPLIFIED APPROACH
CONGENITAL HEART DISEASES: A SIMPLIFIED APPROACHCONGENITAL HEART DISEASES: A SIMPLIFIED APPROACH
CONGENITAL HEART DISEASES: A SIMPLIFIED APPROACH
 
Evaluation of chest pain
Evaluation of chest painEvaluation of chest pain
Evaluation of chest pain
 
Chronic Heart Failure- Pharmacotherapy
Chronic Heart Failure-  PharmacotherapyChronic Heart Failure-  Pharmacotherapy
Chronic Heart Failure- Pharmacotherapy
 
Approach to the child with rash
Approach to the child with rashApproach to the child with rash
Approach to the child with rash
 
Congenital heart diseases in adults
Congenital heart diseases in adults Congenital heart diseases in adults
Congenital heart diseases in adults
 
Meningitis
MeningitisMeningitis
Meningitis
 
Sick sinus syndrome
Sick sinus syndrome Sick sinus syndrome
Sick sinus syndrome
 
Rheumatic heart disease: Acute Rheumatic Fever
Rheumatic heart disease: Acute Rheumatic FeverRheumatic heart disease: Acute Rheumatic Fever
Rheumatic heart disease: Acute Rheumatic Fever
 
Rheumatic Fever and Rheumatic Heart Disease
Rheumatic Fever and Rheumatic Heart DiseaseRheumatic Fever and Rheumatic Heart Disease
Rheumatic Fever and Rheumatic Heart Disease
 
Acute MI - NSTEMI
Acute MI - NSTEMIAcute MI - NSTEMI
Acute MI - NSTEMI
 
Sepsis
SepsisSepsis
Sepsis
 
Myocarditis in children
Myocarditis in childrenMyocarditis in children
Myocarditis in children
 
5 infective endocarditis
5 infective endocarditis5 infective endocarditis
5 infective endocarditis
 
Cardiomyopathy
CardiomyopathyCardiomyopathy
Cardiomyopathy
 
Pneumonia
PneumoniaPneumonia
Pneumonia
 
Rheumatic heart disease
Rheumatic heart diseaseRheumatic heart disease
Rheumatic heart disease
 
Dr. Rabin Rheumatic Heart Disease
Dr. Rabin Rheumatic Heart Disease Dr. Rabin Rheumatic Heart Disease
Dr. Rabin Rheumatic Heart Disease
 

Similar to Rheumatic fever

Rheumatic fever and heart disease
Rheumatic fever and heart diseaseRheumatic fever and heart disease
Rheumatic fever and heart disease
Swapna Pillai
 
rheumaticheartdisease-171013103220 (1).pdf
rheumaticheartdisease-171013103220 (1).pdfrheumaticheartdisease-171013103220 (1).pdf
rheumaticheartdisease-171013103220 (1).pdf
jiregnaetichadako
 
management of acute rheumatic fever
management of acute rheumatic fevermanagement of acute rheumatic fever
management of acute rheumatic fever
Basem Enany
 
rheumatic_feve for dentist 201`6--DR MAGDI SASI
rheumatic_feve for dentist 201`6--DR MAGDI SASIrheumatic_feve for dentist 201`6--DR MAGDI SASI
rheumatic_feve for dentist 201`6--DR MAGDI SASI
cardilogy
 

Similar to Rheumatic fever (20)

Acute rheumatic fever in Children
Acute rheumatic fever in ChildrenAcute rheumatic fever in Children
Acute rheumatic fever in Children
 
Rheumatic fever and heart disease
Rheumatic fever and heart diseaseRheumatic fever and heart disease
Rheumatic fever and heart disease
 
acute Rheumatic fever for UGs.pptx
acute Rheumatic fever for UGs.pptxacute Rheumatic fever for UGs.pptx
acute Rheumatic fever for UGs.pptx
 
Rheumatic fever
Rheumatic feverRheumatic fever
Rheumatic fever
 
Acute rheumatic fever.pptx
Acute rheumatic fever.pptxAcute rheumatic fever.pptx
Acute rheumatic fever.pptx
 
Systemic Sclerosis 2017
Systemic Sclerosis 2017Systemic Sclerosis 2017
Systemic Sclerosis 2017
 
Rheumatic heart disease
Rheumatic heart disease Rheumatic heart disease
Rheumatic heart disease
 
Acute rheumatic fever & Rheumatic Heart Disease
Acute rheumatic fever & Rheumatic Heart DiseaseAcute rheumatic fever & Rheumatic Heart Disease
Acute rheumatic fever & Rheumatic Heart Disease
 
Acute rheumatic fever
Acute rheumatic feverAcute rheumatic fever
Acute rheumatic fever
 
Rheumatic fever in pediatrics
Rheumatic fever in pediatricsRheumatic fever in pediatrics
Rheumatic fever in pediatrics
 
Rheumatic heart disease
Rheumatic heart diseaseRheumatic heart disease
Rheumatic heart disease
 
rheumaticheartdisease-171013103220 (1).pdf
rheumaticheartdisease-171013103220 (1).pdfrheumaticheartdisease-171013103220 (1).pdf
rheumaticheartdisease-171013103220 (1).pdf
 
Rheumatic Heart disease
Rheumatic Heart diseaseRheumatic Heart disease
Rheumatic Heart disease
 
Acute rheumatic fever
Acute rheumatic feverAcute rheumatic fever
Acute rheumatic fever
 
rheumatic_fever.ppt
rheumatic_fever.pptrheumatic_fever.ppt
rheumatic_fever.ppt
 
management of acute rheumatic fever
management of acute rheumatic fevermanagement of acute rheumatic fever
management of acute rheumatic fever
 
Arf
ArfArf
Arf
 
Adult onset-still-disease-1
Adult onset-still-disease-1Adult onset-still-disease-1
Adult onset-still-disease-1
 
seminar on ARF.pptx
seminar on ARF.pptxseminar on ARF.pptx
seminar on ARF.pptx
 
rheumatic_feve for dentist 201`6--DR MAGDI SASI
rheumatic_feve for dentist 201`6--DR MAGDI SASIrheumatic_feve for dentist 201`6--DR MAGDI SASI
rheumatic_feve for dentist 201`6--DR MAGDI SASI
 

More from Shadab Ahmad

More from Shadab Ahmad (20)

Stemi
StemiStemi
Stemi
 
Post pci management of acs
Post pci management of acsPost pci management of acs
Post pci management of acs
 
Acute coronary syndrome
Acute coronary syndromeAcute coronary syndrome
Acute coronary syndrome
 
Direct Oral Anticoagulants in Patients With Atrial Fibrillation and Liver Dis...
Direct Oral Anticoagulants in Patients With Atrial Fibrillation and Liver Dis...Direct Oral Anticoagulants in Patients With Atrial Fibrillation and Liver Dis...
Direct Oral Anticoagulants in Patients With Atrial Fibrillation and Liver Dis...
 
Residual Inflammatory Risk in Patients With Low LDL Cholesterol Levels Underg...
Residual Inflammatory Risk inPatients With Low LDL CholesterolLevels Underg...Residual Inflammatory Risk inPatients With Low LDL CholesterolLevels Underg...
Residual Inflammatory Risk in Patients With Low LDL Cholesterol Levels Underg...
 
Transcatheter Aortic-Valve Replacement with a Balloon-Expandable Valve in Low...
Transcatheter Aortic-Valve Replacement with a Balloon-Expandable Valve in Low...Transcatheter Aortic-Valve Replacement with a Balloon-Expandable Valve in Low...
Transcatheter Aortic-Valve Replacement with a Balloon-Expandable Valve in Low...
 
Infusion Needle Radiofrequency Ablation for Treatment of Refractory Ventricul...
Infusion Needle Radiofrequency Ablation for Treatment of Refractory Ventricul...Infusion Needle Radiofrequency Ablation for Treatment of Refractory Ventricul...
Infusion Needle Radiofrequency Ablation for Treatment of Refractory Ventricul...
 
Percutaneous Transcatheter Mitral Valve Replacement
Percutaneous Transcatheter Mitral Valve ReplacementPercutaneous Transcatheter Mitral Valve Replacement
Percutaneous Transcatheter Mitral Valve Replacement
 
Long-Term Durability of Transcatheter Aortic Valve Prostheses
Long-Term Durability of Transcatheter Aortic Valve ProsthesesLong-Term Durability of Transcatheter Aortic Valve Prostheses
Long-Term Durability of Transcatheter Aortic Valve Prostheses
 
Cardiac Troponin Elevation in Patients Without a Specific Diagnosis
Cardiac Troponin Elevation in Patients Without a Specific DiagnosisCardiac Troponin Elevation in Patients Without a Specific Diagnosis
Cardiac Troponin Elevation in Patients Without a Specific Diagnosis
 
His Resynchronization Versus Biventricular Pacing in Patients With Heart Fail...
His Resynchronization VersusBiventricular Pacing inPatients With Heart Fail...His Resynchronization VersusBiventricular Pacing inPatients With Heart Fail...
His Resynchronization Versus Biventricular Pacing in Patients With Heart Fail...
 
Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome
Alirocumab and Cardiovascular Outcomes after Acute Coronary SyndromeAlirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome
Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome
 
Angiotensin neprilysin inhibition in acute decompensated heart failure
Angiotensin neprilysin inhibition in acute decompensated heart failureAngiotensin neprilysin inhibition in acute decompensated heart failure
Angiotensin neprilysin inhibition in acute decompensated heart failure
 
Rivaroxaban for thromboprophylaxis after Hospitalization for Medical Illness
Rivaroxaban for thromboprophylaxis after Hospitalization for Medical IllnessRivaroxaban for thromboprophylaxis after Hospitalization for Medical Illness
Rivaroxaban for thromboprophylaxis after Hospitalization for Medical Illness
 
A Study of Chest X-Ray PA View & Lateral Views
A Study of Chest X-Ray PA View & Lateral ViewsA Study of Chest X-Ray PA View & Lateral Views
A Study of Chest X-Ray PA View & Lateral Views
 
A No-Prophylaxis Platelet-Transfusion Strategy for Hematologic Cancers
A No-Prophylaxis Platelet-Transfusion Strategyfor Hematologic CancersA No-Prophylaxis Platelet-Transfusion Strategyfor Hematologic Cancers
A No-Prophylaxis Platelet-Transfusion Strategy for Hematologic Cancers
 
Recent advances in diagnosis &amp; management of SLE
Recent advances in diagnosis &amp; management of SLERecent advances in diagnosis &amp; management of SLE
Recent advances in diagnosis &amp; management of SLE
 
Probability of cancer in pulmonary nodules detected on first screening CT scan
Probability of cancer in pulmonary nodules detected on first screening CT scanProbability of cancer in pulmonary nodules detected on first screening CT scan
Probability of cancer in pulmonary nodules detected on first screening CT scan
 
Influence of the Timing of Malaria Infection during pregnancy on birth weight...
Influence of the Timing of Malaria Infection during pregnancy on birth weight...Influence of the Timing of Malaria Infection during pregnancy on birth weight...
Influence of the Timing of Malaria Infection during pregnancy on birth weight...
 
Endocarditis in adults with bacterial meningitis
Endocarditis in adults with bacterial meningitisEndocarditis in adults with bacterial meningitis
Endocarditis in adults with bacterial meningitis
 

Recently uploaded

THORACOTOMY . SURGICAL PERSPECTIVES VOL 1
THORACOTOMY . SURGICAL PERSPECTIVES VOL 1THORACOTOMY . SURGICAL PERSPECTIVES VOL 1
THORACOTOMY . SURGICAL PERSPECTIVES VOL 1
DR SETH JOTHAM
 

Recently uploaded (20)

"Central Hypertension"‚ in China: Towards the nation-wide use of SphygmoCor t...
"Central Hypertension"‚ in China: Towards the nation-wide use of SphygmoCor t..."Central Hypertension"‚ in China: Towards the nation-wide use of SphygmoCor t...
"Central Hypertension"‚ in China: Towards the nation-wide use of SphygmoCor t...
 
Anuman- An inference for helpful in diagnosis and treatment
Anuman- An inference for helpful in diagnosis and treatmentAnuman- An inference for helpful in diagnosis and treatment
Anuman- An inference for helpful in diagnosis and treatment
 
Hemodialysis: Chapter 2, Extracorporeal Blood Circuit - Dr.Gawad
Hemodialysis: Chapter 2, Extracorporeal Blood Circuit - Dr.GawadHemodialysis: Chapter 2, Extracorporeal Blood Circuit - Dr.Gawad
Hemodialysis: Chapter 2, Extracorporeal Blood Circuit - Dr.Gawad
 
Creating Accessible Public Health Communications
Creating Accessible Public Health CommunicationsCreating Accessible Public Health Communications
Creating Accessible Public Health Communications
 
Book Trailer: PGMEE in a Nutshell (CEE MD/MS PG Entrance Examination)
Book Trailer: PGMEE in a Nutshell (CEE MD/MS PG Entrance Examination)Book Trailer: PGMEE in a Nutshell (CEE MD/MS PG Entrance Examination)
Book Trailer: PGMEE in a Nutshell (CEE MD/MS PG Entrance Examination)
 
DECIPHERING COMMON ECG FINDINGS IN ED.pptx
DECIPHERING COMMON ECG FINDINGS IN ED.pptxDECIPHERING COMMON ECG FINDINGS IN ED.pptx
DECIPHERING COMMON ECG FINDINGS IN ED.pptx
 
Compare home pulse pressure components collected directly from home
Compare home pulse pressure components collected directly from homeCompare home pulse pressure components collected directly from home
Compare home pulse pressure components collected directly from home
 
Introducing VarSeq Dx as a Medical Device in the European Union
Introducing VarSeq Dx as a Medical Device in the European UnionIntroducing VarSeq Dx as a Medical Device in the European Union
Introducing VarSeq Dx as a Medical Device in the European Union
 
Is preeclampsia and spontaneous preterm delivery associate with vascular and ...
Is preeclampsia and spontaneous preterm delivery associate with vascular and ...Is preeclampsia and spontaneous preterm delivery associate with vascular and ...
Is preeclampsia and spontaneous preterm delivery associate with vascular and ...
 
The hemodynamic and autonomic determinants of elevated blood pressure in obes...
The hemodynamic and autonomic determinants of elevated blood pressure in obes...The hemodynamic and autonomic determinants of elevated blood pressure in obes...
The hemodynamic and autonomic determinants of elevated blood pressure in obes...
 
Non-Invasive assessment of arterial stiffness in advanced heart failure patie...
Non-Invasive assessment of arterial stiffness in advanced heart failure patie...Non-Invasive assessment of arterial stiffness in advanced heart failure patie...
Non-Invasive assessment of arterial stiffness in advanced heart failure patie...
 
𝕔ALL #𝕘IRLS Service in Jaipur %(8901183002)# Jaipur #𝕔ALL #𝕘IRLS
𝕔ALL #𝕘IRLS Service in Jaipur %(8901183002)#  Jaipur #𝕔ALL #𝕘IRLS𝕔ALL #𝕘IRLS Service in Jaipur %(8901183002)#  Jaipur #𝕔ALL #𝕘IRLS
𝕔ALL #𝕘IRLS Service in Jaipur %(8901183002)# Jaipur #𝕔ALL #𝕘IRLS
 
Vaccines: A Powerful and Cost-Effective Tool Protecting Americans Against Dis...
Vaccines: A Powerful and Cost-Effective Tool Protecting Americans Against Dis...Vaccines: A Powerful and Cost-Effective Tool Protecting Americans Against Dis...
Vaccines: A Powerful and Cost-Effective Tool Protecting Americans Against Dis...
 
DIGITAL RADIOGRAPHY-SABBU KHATOON .pptx
DIGITAL RADIOGRAPHY-SABBU KHATOON  .pptxDIGITAL RADIOGRAPHY-SABBU KHATOON  .pptx
DIGITAL RADIOGRAPHY-SABBU KHATOON .pptx
 
End Feel -joint end feel - Normal and Abnormal end feel
End Feel -joint end feel - Normal and Abnormal end feelEnd Feel -joint end feel - Normal and Abnormal end feel
End Feel -joint end feel - Normal and Abnormal end feel
 
Effects of vaping e-cigarettes on arterial health
Effects of vaping e-cigarettes on arterial healthEffects of vaping e-cigarettes on arterial health
Effects of vaping e-cigarettes on arterial health
 
Antiplatelets in IHD, Dose Duration, DAPT vs SAPT
Antiplatelets in IHD, Dose Duration, DAPT vs SAPTAntiplatelets in IHD, Dose Duration, DAPT vs SAPT
Antiplatelets in IHD, Dose Duration, DAPT vs SAPT
 
THORACOTOMY . SURGICAL PERSPECTIVES VOL 1
THORACOTOMY . SURGICAL PERSPECTIVES VOL 1THORACOTOMY . SURGICAL PERSPECTIVES VOL 1
THORACOTOMY . SURGICAL PERSPECTIVES VOL 1
 
Couples presenting to the infertility clinic- Do they really have infertility...
Couples presenting to the infertility clinic- Do they really have infertility...Couples presenting to the infertility clinic- Do they really have infertility...
Couples presenting to the infertility clinic- Do they really have infertility...
 
Temporal, Infratemporal & Pterygopalatine BY Dr.RIG.pptx
Temporal, Infratemporal & Pterygopalatine BY Dr.RIG.pptxTemporal, Infratemporal & Pterygopalatine BY Dr.RIG.pptx
Temporal, Infratemporal & Pterygopalatine BY Dr.RIG.pptx
 

Rheumatic fever

  • 2. INTRODUCTION Rheumatic fever- a multifactorial disease that follows GAS pharyngitis in a susceptible individual who lives under deprived social conditions, characterized by acute inflammation of the heart, joints, skin, subcutaneous tissue & CNS, that gives rise to typical clinical feature including • Arthritis • Carditis • Chorea • Subcutaneous nodules & • Erythema marginatum • Latent period of 2-3 weeks following GAS pharangitis • Destructive effects on heart valves leads to RHD with serious hemodynamic disturbances causing HF, stroke & infective endocarditis
  • 3. EPIDEMIOLOGY • Ages 4-15 years are most susceptible • In developing countries (such as Saudi Arabia & India), juvenile MS may occur at age 3-5 years • Rare in <3 years
  • 4. PATHOGENESIS • GAS pharyngitis triggers an autoimmune response to epitopes in the organism that cross react with similar epitopes in the heart, brain, joints and skin , and repeated episodes of rheumatic fever lead to RHD (theory of molecular mimicry)
  • 6. ARTHRITIS • Joint involvement is more common (almost 100%), more severe in young adults than in teenagers (82%), & children(66%) • Migratory arthritis- sequential involvement of joints with inflammation resolving in one joint & then begins in another joint (sometimes may be additive) • Usually Subside within days to 1 week, may last for another 1- 2 weeks, if persist after 4 weeks, it becomes necessary to consider other conditions such as juvenile idiopathic arthritis or SLE • Large joints- knee, ankle, elbow & wrists are most frequently involved • Hip , shoulder, and small joints of hands & feet are less frequently involved • Respond promptly to NSAIDS
  • 7. JACCOUD ARTHRITIS • Chronic post-rheumatic fever arthropathy • Ulnar deviation of fingers (esp. 4th & 5th finfers), flexion of metacarpophalangeal joints, & hyperextension of proximal interphalangeal joints (i.e., swan neck deformity) • Usually painless & no signs of inflammation • Results from recurrent inflammation of fibrous articular capsule & there are no true erosion on xray • Rheumatoid factors are usually negative
  • 8. CARDITIS • Incidence of carditis varies with age with first attack of rheumatic fever: • 90-92% of children age<3 years • 50% of children age 3-6 years • 32% of teenagers age 14-17 years • 15% of adults • Symptoms & signs depend on involvement of endocardium (heart valves), myocardium & pericardium • Most serious manifestation of rheumatic fever
  • 9. ENDOCARDITIS/VALVULITIS • Almost always associated with a murmur of valvulitis • An universal finding in rheumatic carditis, whereas the presence of pericarditis or myocarditis is variable • Inflammation, edema & fibrin deposits on valve leaflets along the line of closure(verrucous vegetations) • Map-like areas of thickened, roughened, and wrinkled part of the endocardium in the left atrium caused by regurgitant jets of MR (MacCallum plaque) • The most common valvular lesion is MR causing an apical PSM, pathogenesis include valvulitis, mitral annular dilatation, leaflet prolapse or chordal rupture, AR is less common. • Stenotic lesions are uncommon in the early stages , but a transient apical mid-diastolic murmur (Carey-Coombs) may occur in association with MR • With H/O previous RHD, a change in character of murmurs or appearance of a new murmur will indicate the presence of acure rheumatic carditis.
  • 10. MYOCARDITIS • Almost always associated with valvulitis • Should be accompanied by an apical systolic or basal diastolic murmur. • May develop cardiomegaly & CHF • ECG changes include varying degree of heart block, with 1st degree heart block are usually asymptomatic • Patients with 2nd & 3rd degree heart block are symptomatic and require a pacemaker if they develop CHF • Aschoff body consists of a focus of fibrinoid necrosis (site of Ag-Ab reaction) surrounded by activated histiocytes (Anitschkow’s cells/caterpillar cells) & lymphocytes
  • 11. PERICARDITIS • Detected clinically in 10% of patients • Associated with anterior chest pain & pericardial friction rub • Pericardial effusion may be large, but cardiac tamponade is rare • Constrictive pericarditis does not occur • “Bread & butter” appearance due to fibrinous inflammation
  • 12. MINIMUM ECHO CRITERIA FOR DIAGNOSIS OF VALVULAR REGURGITATION CAUSED BY RHEUMATIC CARDITIS • All four Doppler criteria must be met • A regurgitant jet length should be measured from the vena contracta to the last pixel of regurgitant color on nonmagnified images. PATHOLOGIC MR PATHOLOGIC AR 1. Seen in at least two views 1. Seen in at least two views 2. In at least one view, jet length is ≥2 cm 2. In at least one view, jet length is ≥1 cm 3. Peak velocity ≥3 m/sec 3. Peak velocity ≥3 m/sec 4. Pansystolic jet in at least one envelope 4. Pansystolic jet in at least one envelope.
  • 13. SYDENHAM CHOREA • May be the only presenting manifestation of rheumatic fever • Female predominance • Latent period 6-8 week (longer than arthritis & carditis, 2-3 weeks) • Usually last for 8-15 weeks (may last for 1 week to 2 years) • Characterized by the presence of involuntary, purposeless, jerky movements of hands, arms, shoulders, feet, legs, face & trunk associated with hypotonia & weakness, sometimes may be unilateral (hemichorea) • The purposeless movements interfere with voluntary activity & disappear during sleep • Jack-in-the-box tongue • Milking sign • Chorea does not occur simultaneously with arthritis but may coexist with carditis
  • 14. SYDENHAM’S CHOREA VS PANDAS Sydenham’s chorea PANDAS Age of onset 5-15 years 3 years – puberty Gender Female predominance Male > Female Pathogen Several M-strains of Streptococcal bacteria No unique strain identified Incidence of psychiatric disorders in 1st degree relatives No studies 39% motor or vocal tics, 26% OCD Neurological abnormalities Hypotonia, Darting tongue, Milkmaid sign, Pronator sign, choreic hand, dysarthria Motor hyperactivity, adventitious movements such as choreiform movements Psychiatric manifestation Emotional liability, anxiety, tics, OCD in 70% of patients Emotional liability, separation anxiety, night time fears, oppositional behaviors ASO titer Elevated in 80% of cases Temporal relation with ASO Duration of symptoms Usually resolve in 1-6 months, may persist up to 2 years Remitting-relapsing course Anti-basal ganglia antibodies 40, 45, 60 kDa autoantigens molecule 60kDa ABGA very frequently present MRI Volumetric increase in caudate, putamen & globus pallidus Volumetric increase in caudate, putamen, & globus pallidus Treatment Benzathine penicillin prophylaxis 1.2 MU I/M 3 weekly IVIG & plasma exchange, tonsilectomy
  • 15. SUBCUTANEOUS NODULES • Resemble the nodules of rheumatoid arthritis • May be detected over occiput, elbows(over olecranon), knees, ankles, and Achilles tandons. • Usually firm, painless, & freely movable over the subcutaneous tissue • Size 0.5-2 cm & tend to occur in crops • Usually smaller, more discrete, & persistent than rheumatoid nodules • Persist for few weeks but seldom >1 month • Multiple crops may be related to the severity of rheumatic carditis
  • 16. ERYTHEMA MARGINATUM • Occur on upper arms or trunk, but not the face • The rash is evanescent, pink, and nonpruritic • Extend centrifugally while the skin at the center returns to normal • Has an irregular serpiginous border • Rash become more prominent after a hot shower
  • 17. DIFFERENTIAL DIAGNOSIS ARTHRITIS CARDITIS CHOREA Rheumatoid arthritis Viral myocarditis Huntington chorea Reactive arthritis (eg., Shigella, Salmonella, Yersinia) Viral pericarditis Wilson disease Serum sickness Infective endocarditis SLE Sickle cell disease Kawasaki disease Cerebral palsy Malignancy Congenital heart disease Tics SLE Mitral valve prolapse Hyperactivity Lyme disease Innocent murmur Gonococcal infection
  • 18. MINOR MANIFESTATIONS Fever • Usually raised during attacks • Ranges from 38.4˚C to 40˚C • Usually decreases within 1 week & rarely last >4 weeks Abdominal pain • May mimic acute appendicitis Epistaxis Rapid sleeping pulse rate, tachycardia out of proportion to fever Malaise Anemia Rheumatic pneumonia
  • 19. EVOLUTION OF JONES CRITERIA
  • 20. 2015 AHA-REVISED JONES CRITERIA FOR DIAGNOSIS OF RHEUMATIC FEVER MAJOR CRITERIA LOW-RISK POPULATIONS MODERATE & HIGH- RISK POPULATIONS 1. Carditis (clinical/subclinical) Carditis (clinical/subclinical) 2. Arthritis (polyarthritis only) Arthritis (including polyarthritis, monoarthritis/ polyarthralgia) 3. Chorea Chorea 4. Erythema marginatum Erythema marginatum 5. Subcutaneous nodules Subcutaneous nodules MINOR CRITERIA LOW RISK POPULATIONS MODERATE & HIGH RISK POPULATIONS 1. Polyarthralgia Monoarthralgia 2. Fever (≥38.5˚C) Fever (≥38˚C) 3. ESR ≥60 mm in the 1st hour &/or CRP ≥3.0 mg/dl ESR ≥30 mm in the 1st hour &/or CRP ≥3.0 mg/dl 4. Prolonged PR interval, after accounting for age variability (unless carditis is a major criterion) Prolonged PR interval, after accounting for age variability (unless carditis is a major criterion) • Joint manifestations are considered in either the major or the minor category, but not in both categories in the same patient • Low-risk communities are defined as having an ARF incidence of ≤2 per 100,000 school-aged children (usually 5 to 14 years old) per year, or an all-age prevalence of RHD of ≤1 per 1000 population per year
  • 21. DIAGNOSIS • The initial diagnosis of ARF is made if, in the presence of preceding GAS infection, two major criteria or one major and two minor criteria are present. • The diagnosis of recurrent ARF requires two major, one major and two minor, or three minor criteria in the presence of preceding GAS infection. • Evidence of preceding GAS infection, (essential for diagnosis), may be obtained from • Throat swab culture (only positive in approx. 11% of patients), or • By demonstrating a rising titer of antistreptococcal antibodies, either ASO or anti-Dnase B, or • By a positive rapid group A streptococcal carbohydrate antigen test in a child whose clinical presentation suggests a high pretest probability of streptococcal pharyngitis.
  • 22. POSSIBLE RHEUMATIC FEVER • The 2015 Jones criteria also recognize the clinical entity of “possible rheumatic fever” • Applied in part of the world where rheumatic fever remains common and where it is not possible to fulfill the Jones criteria because of a lack of lab facilities to conduct the recommended investigations of a patient with suspected rheumatic fever. • When a diagnosis of possible rheumatic fever is made, it is reasonable to consider offering 12 months of secondary prophylaxis, followed by reevaluation based on history, physical examination, and repeat echocardiogram.
  • 23. INVESTIGATIONS IN SUSPECTED RHEUMATIC FEVER Recommended for All Cases Test for Alternative Diagnoses, Depending on Clinical Features WBC count Repeated blood culture with temperature spikes if infective endocarditis is suspected ESR or CRP Joint aspirate for possible septic arthritis (microscopy & culture) Throat swab before giving antibiotics for GAS culture Copper, ceruloplasmin, ANA, and drug screen for choreiform movements Blood culture, if febrile Serology and autoimmune markers for arboviral, autoimmune, or reactive arthritis Antistreptococcal serology: both ASO & antiDNase B titers (repeat after 10-14 days if first test is not confirmatory) Peripheral blood smear for sickle cell disease ECG Chest X-ray Echocardiogram
  • 24. TREATMENT • Bed rest- to lessen joint pain • Ambulation can usually be started once the fever has subsided and acute phase reactants are returning to normal • Sternous exertion should be avoided, esp. for those with carditis • Antibiotics • Benzathine benzylpenicillin (Penicillin G)- 1.2 MU I/M single dose (50% if weight <30 kg) • Phenoxymethylpenicillin (Penicillin VK)- 250-500 mg oral three times daily for 10 days • Erythromycin ethylsuccinate- oral for 10 days • Anti-inflammatory agents • Aspirin 100mg/kg/day in four to five divided doses for approx. 1 month or until inflammation has subsided (for milder attack with little or no carditis) • Prednisone 1-2 mg/kg/day for 2-3 months then graduallt weaned (for more severe cases)
  • 25. SECONDARY PREVENTION ANTIBIOTICS DOSE Benzathine benzylpenicillin 1.2 MU I/M every 3-4 weeks (for adults & children ≥ 30 kg weight) 0.6 MU I/M every 3-4 weeks (for children < 30 kg weight) Penicillin V 250 mg oral twice daily Sulfonamides (sulfadiazine, sulfadoxine, & sulfisoxazole) 1 g/day (for adults & children ≥ 30 kg weight) 0.5 g/day (for children < 30 kg weight) Erythromycin 250 mg twice daily DURATION OF SECONDARY PROPHYLAXIS CATEGORY OF PATIENTS DURATION Patients without proven carditis For 5 years after last attack or until 18 years of age (whichever is longer) Patient with carditis (mild MR or healed carditis) For 10 years after last attack or at least until 25 years of age (whichever is longer) More severe valvular disease Lifelong After valve surgery Lifelong

Editor's Notes

  1. PANDAS=paediatric autoimmune neuropsychiatric disorder associated with streptococcal infection